A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer
Clinical trial NCT05787561 · RECRUITING
Trial details
- NCT number
- NCT05787561
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-15
- Primary completion
- 2027-03-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.